Literature DB >> 31847530

The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity.

Alessandra Scagliola1, Francesco Mainini1, Simone Cardaci1.   

Abstract

Significance: The tricarboxylic acid (TCA) cycle is a housekeeping metabolic pathway essential for generation of energy and biosynthetic intermediates. Alterations of the TCA cycle play a pivotal role in oncogenesis and inflammation. As such, some metabolic vulnerabilities, imposed by TCA cycle dysfunction in cancer, have been identified. Similarly, the TCA cycle appeared as an actionable pathway in immunopathologies. Recent Advances: Metabolic changes accompanying cell transformation have been usually considered as adaptive mechanisms to malignant transformation. The identification of oncogenic mutations in some TCA cycle enzymes changed this view, indicating altered mitochondrial metabolism as an instrumental mechanism for cancer initiation. Similarly, the observation that TCA cycle-derived metabolites have multiple signaling roles in immune cells supports the idea of this pathway as a metabolic rheostat of immune responses. Critical Issues: This review summarizes the crucial role of the TCA cycle in pathophysiology describing the post-translational and epigenetic impact of oncometabolites accumulation in cancer and immune cells. Future Directions: Additional studies will be necessary to further explore the role of oncometabolites in paracrine signaling and to identify genuine metabolic and nutritional liabilities imposed by TCA cycle dysfunction in cancer, hardly to be escaped by resistance mechanisms.

Entities:  

Keywords:  cancer; inflammation; metabolic vulnerabilities; metabolism; oncometabolites

Mesh:

Year:  2020        PMID: 31847530     DOI: 10.1089/ars.2019.7974

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  9 in total

1.  Irg1-itaconate axis protects against acute kidney injury via activation of Nrf2.

Authors:  Dongdong Zhu; Yuanyu Zhao; Yi Luo; Xiaoqian Qian; Zhen Zhang; Gengru Jiang; Fengfu Guo
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 2.  Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.

Authors:  Valentin Lacombe; Guy Lenaers; Geoffrey Urbanski
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

Review 3.  Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation.

Authors:  Chelsea Schiliro; Bonnie L Firestein
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

4.  Advances in Nutritional Epigenetics-A Fresh Perspective for an Old Idea. Lessons Learned, Limitations, and Future Directions.

Authors:  Lynda Sedley
Journal:  Epigenet Insights       Date:  2020-12-18

Review 5.  Metabolic Reprogramming and Reactive Oxygen Species in T Cell Immunity.

Authors:  Hao-Yun Peng; Jason Lucavs; Darby Ballard; Jugal Kishore Das; Anil Kumar; Liqing Wang; Yijie Ren; Xiaofang Xiong; Jianxun Song
Journal:  Front Immunol       Date:  2021-03-31       Impact factor: 7.561

6.  Determination of Breast Metabolic Phenotypes and Their Associations With Immunotherapy and Drug-Targeted Therapy: Analysis of Single-Cell and Bulk Sequences.

Authors:  Ming Bai; Chen Sun
Journal:  Front Cell Dev Biol       Date:  2022-02-14

Review 7.  Recent advances of IDH1 mutant inhibitor in cancer therapy.

Authors:  Wangqi Tian; Weitong Zhang; Yifan Wang; Ruyi Jin; Yuwei Wang; Hui Guo; Yuping Tang; Xiaojun Yao
Journal:  Front Pharmacol       Date:  2022-08-24       Impact factor: 5.988

8.  Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma.

Authors:  Zhang Ye; Shenqi Zhang; Jiayang Cai; Liguo Ye; Lun Gao; Yixuan Wang; Shiao Tong; Qian Sun; Yu Wu; Xiaoxing Xiong; Qianxue Chen
Journal:  Front Oncol       Date:  2022-08-18       Impact factor: 5.738

9.  Cuproptosis-Related genes in the prognosis of colorectal cancer and their correlation with the tumor microenvironment.

Authors:  Weiqiang Wu; Jingqing Dong; Yang Lv; Dongmin Chang
Journal:  Front Genet       Date:  2022-09-28       Impact factor: 4.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.